atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma… - Circulation …, 2021 - Am Heart Assoc
Rationale: Anthracycline-induced cardiotoxicity (AIC) is a major side effect that limits the use
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity.
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma… - Circulation …, 2021 - europepmc.org
Objective: We aim to elucidate the dynamic autophagic defects in AIC, and to identify a
mechanism-based therapy via both genetic and pharmacological studies. Method and …
mechanism-based therapy via both genetic and pharmacological studies. Method and …
[HTML][HTML] atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma… - Circulation …, 2021 - ncbi.nlm.nih.gov
Objective: We aim to elucidate the dynamic autophagic defects in AIC, and to identify a
mechanism-based therapy via both genetic and pharmacological studies. Method and …
mechanism-based therapy via both genetic and pharmacological studies. Method and …
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma… - Circulation …, 2021 - Am Heart Assoc
OBJECTIVE: We aim to elucidate the dynamic autophagic defects in AIC and to identify a
mechanism-based therapy via both genetic and pharmacological studies. METHOD AND …
mechanism-based therapy via both genetic and pharmacological studies. METHOD AND …
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu… - Circulation …, 2021 - pubmed.ncbi.nlm.nih.gov
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity atg7-Based
Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity Circ Res. 2021 Oct;129(8):e166-e182 …
Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity Circ Res. 2021 Oct;129(8):e166-e182 …
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu… - Circulation …, 2021 - mayoclinic.elsevierpure.com
Rationale: Anthracycline-induced cardiotoxicity (AIC) is a major side effect that limits the use
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
[PDF][PDF] atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma, X Ma… - researchgate.net
Rationale: Anthracycline-induced cardiotoxicity (AIC) is a major side effect that limits the use
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
atg7 -Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma, X Ma… - Circulation …, 2021 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Rationale:</jats: title>< jats: p> Anthracycline-induced
cardiotoxicity (AIC) is a major side effect that limits the use of anthracyclines as effective …
cardiotoxicity (AIC) is a major side effect that limits the use of anthracyclines as effective …
atg7-Based Autophagy Activation Reverses Doxorubicin-Induced Cardiotoxicity
Y Wang, X Lu, X Wang, Q Qiu, P Zhu, L Ma… - Circulation …, 2021 - ingentaconnect.com
Rationale: Anthracycline-induced cardiotoxicity (AIC) is a major side effect that limits the use
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …
of anthracyclines as effective chemotherapeutics. No mechanism-based therapy is available …